Clinical Trial

A Comprehensive Digital Care Program for Migraine Management

Recruiting
View on ClinicalTrials.gov →
Summary
This study evaluates the clinical effectiveness of the Enso for Migraine program, a comprehensive digital care program combining an FDA-cleared neuromodulation wearable device (Enso), personalized exercise therapy, and a dedicated care team, in reducing migraine frequency among adults with episodic or chronic migraine.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-06-04.
Trial Details
NCT Number NCT07642414
Lead Sponsor Hinge Health, Inc
Conditions Migraine, Migraine With Aura, Migraine Without Aura
Enrollment 140 participants
Start Date 2026-06
Primary Completion 2026-10 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2026-06-16